Results 81 to 90 of about 2,489,205 (210)

Regulatory T Cells in Health and Disease

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Regulatory T cells (Tregs) arise through distinct developmental pathways and adapt to specialized tissue niches to maintain immune tolerance, barrier integrity, and metabolic homeostasis. In disease, Tregs undergo context‐dependent changes, ranging from functional insufficiency and lineage instability in autoimmune, inflammatory, cardiovascular, and ...
Mingyi Li   +4 more
wiley   +1 more source

Modern management of leukemoid reactions

open access: yesInfusion & Chemotherapy
. Leukemoid reaction (LR) is a transient hematological syndrome of reactive nature characterized by persistent leukocytosis of more than 50,000 cells/µL.
D.V. Dobrianskyi   +6 more
doaj   +1 more source

Toxoplasma‐related cholangiohepatitis diagnosed by bile cytology in an immunocompetent cat

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Abstract An 8‐year‐old, male, neutered domestic shorthair cat was presented for investigation of a 2‐week history of hyporexia, lethargy and jaundice. Diagnostic investigations revealed hyperbilirubinaemia, increased liver enzyme activity and thickening of the gall bladder wall with a multilayer appearance.
Anna Halka   +3 more
wiley   +1 more source

Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6 [PDF]

open access: yes, 2013
The authors acknowledge TENOVUS Tayside for funding the studyTenovin-6 (Tnv-6) is a bioactive small molecule with anti-neoplastic activity. Inhibition of the Sirtuin class of protein deacetylases with activation of p53 function is associated with the pro-
Coates, Philip J.   +44 more
core   +1 more source

Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3‐ITD–Positive AML

open access: yesCancer Science, Volume 117, Issue 11, Page 3108-3120, November 2026.
ABSTRACT Quizartinib is a FMS‐like tyrosine kinase 3 (FLT3) inhibitor indicated for FLT3 internal tandem duplication (FLT3‐ITD)–positive acute myeloid leukemia (AML). We aimed to evaluate quizartinib resistance mechanisms, in addition to efficacy and safety outcomes, in patients with relapsed or refractory FLT3‐ITD–positive AML.
Yuichiro Semba   +21 more
wiley   +1 more source

Outcomes of dietitian involvement with leukemia patients receiving total parenteral nutrition [PDF]

open access: yes, 2002
Plan BThere is an increasing need for justification of medical nutrition therapy given by the dietitian. With health care costs escalating rapidly, practitioners need to demonstrate that they can improve patient outcomes.
Mattson, Christine
core  

A case of palisaded neutrophilic granulomatous dermatitis with subsequent development of chronic myelomonocytic leukemia

open access: yesClinical Case Reports, 2019
Key Clinical Message Palisaded neutrophilic granulomatous dermatitis is a cutaneous marker of a systemic disease. Clinicians’ goal should be directed toward determining an underlying condition. Even if the initial investigation is inconclusive, it may be
Aikaterini Kyriakou   +5 more
doaj   +1 more source

Leptin May Promote Eosinophilic CRSwNP Progression by Enhancing Eosinophil Chemotaxis and Angiogenesis Under a Type 2 Inflammatory Milieu

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 10, Page 1094-1106, October 2026.
ABSTRACT Background Chronic rhinosinusitis with nasal polyp (CRSwNP) is a heterogeneous Type 2 inflammatory disease characterized by enhanced eosinophilic infiltration. Both innate and adaptive immunity are involved in the onset and progression of CRSwNP.
Yuki Sonoda   +4 more
wiley   +1 more source

Incidentally Found Chronic Neutrophilic Leukemia in a Patient with Rectal Cancer [PDF]

open access: yes, 2016
증례는 감염 및 악성종양과 동반되어 백혈병양 반응과의 감별이 어려웠고, 또한 악성종양의 전이와 유사하게 종괴를 형성하여 더욱 감별이 어려웠던 CNL 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다. Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm characterized by sustained neutrophilia, splenomegaly, and ...
이민주   +6 more
core   +1 more source

New Bcr-Abl-independent mechanisms of resistance to imatinib treatment in chronic myelogenous leukaemia patients [PDF]

open access: yes, 2008
Although rare in chronic phase myeloid leukemia (CML), primary or acquired resistance to the treatment with tyrosine kinase inhibitors (TKI) may be observed in the advanced phases of disease.
Esposito, Nicola
core   +1 more source

Home - About - Disclaimer - Privacy